Pharmaceutical compositions and methods of use of 4-pregenen-11 beta-17-21-triol-3,20-dione derivatives

Pharmaceutical compositions and methods of use of 4-pregenen-11 beta-17-21-triol-3,20-dione derivatives

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-111P-17-21-TRIOL-3,20-DIONE DERIVATIVES The present invention relates to pharmaceutical compositions comprising 4-pregenen 11-17-21-trio-3,20-dione derivatives, and their use as pharmaceuticals as modulators of the glucocorticoid receptors...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Edelman, Jeffrey L, Nehme, Alissar
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-111P-17-21-TRIOL-3,20-DIONE DERIVATIVES The present invention relates to pharmaceutical compositions comprising 4-pregenen 11-17-21-trio-3,20-dione derivatives, and their use as pharmaceuticals as modulators of the glucocorticoid receptors (GR) and/or the mineralocorticoid receptors (MR). The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat ocular conditions associated with the glucocorticoid receptors(GR) and/or the mineralocorticoid receptors (MR).